Updates in management of ampullary carcinomas

Preethi K. John; Andromachi S. Kougioumtzopoulou; Konstantinos N. Syrigos; Muhammad Wasif Saif

doi:10.6092/1590-8577%2F2283

Updates in management of ampullary carcinomas

Preethi K. John, Andromachi S. Kougioumtzopoulou, Konstantinos N. Syrigos, Muhammad Wasif Saif

Research output: Contribution to journal › Conference article › peer-review

1 Scopus citations

Abstract

Ampullary carcinomas are rare malignancies representing less than 1% of all gastrointestinal cancers. Given the low incidence rate, there is scarcity of data regarding the survival benefit of the treatment options available. In the 2014 ASCO Gastrointestinal Cancers Symposium there were two abstracts that discussed the role of pancreaticoduodenectomy and adjuvant radiation therapy in ampullary carcinoma. The first study (Abstract #366) demonstrated a decline in morbidity and mortality over time for pancreaticoduodenectomy making it a reasonable option for successful treatment of ampullary carcinoma. The second study (Abstract #282) showed that adjuvant radiation therapy in patients with T2 tumors had improved median survival times compared to patients that did not receive radiation therapy.

Original language	English (US)
Pages (from-to)	140-143
Number of pages	4
Journal	Journal of the Pancreas
Volume	15
Issue number	2
DOIs	https://doi.org/10.6092/1590-8577%2F2283
State	Published - Jan 1 2014
Externally published	Yes
Event	2014 ASCO Gastrointestinal Cancers Symposium - San Francisco, CA, United States Duration: Jan 16 2014 → Jan 18 2014

Keywords

Ampulla of Vater
Neoplasms
Pancreaticoduodenectomy
Radiotherapy

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Hepatology
Endocrinology

Access to Document

10.6092/1590-8577%2F2283

Cite this

@article{25cb328d0aff476291df610e89e9f3c9,

title = "Updates in management of ampullary carcinomas",

abstract = "Ampullary carcinomas are rare malignancies representing less than 1% of all gastrointestinal cancers. Given the low incidence rate, there is scarcity of data regarding the survival benefit of the treatment options available. In the 2014 ASCO Gastrointestinal Cancers Symposium there were two abstracts that discussed the role of pancreaticoduodenectomy and adjuvant radiation therapy in ampullary carcinoma. The first study (Abstract #366) demonstrated a decline in morbidity and mortality over time for pancreaticoduodenectomy making it a reasonable option for successful treatment of ampullary carcinoma. The second study (Abstract #282) showed that adjuvant radiation therapy in patients with T2 tumors had improved median survival times compared to patients that did not receive radiation therapy.",

keywords = "Ampulla of Vater, Neoplasms, Pancreaticoduodenectomy, Radiotherapy",

author = "John, {Preethi K.} and Kougioumtzopoulou, {Andromachi S.} and Syrigos, {Konstantinos N.} and Saif, {Muhammad Wasif}",

year = "2014",

month = jan,

day = "1",

doi = "10.6092/1590-8577%2F2283",

language = "English (US)",

volume = "15",

pages = "140--143",

journal = "Journal of the Pancreas",

issn = "1590-8577",

publisher = "E.S. Burioni Ricerche Bibliografiche",

number = "2",

note = "2014 ASCO Gastrointestinal Cancers Symposium ; Conference date: 16-01-2014 Through 18-01-2014",

}

TY - JOUR

T1 - Updates in management of ampullary carcinomas

AU - John, Preethi K.

AU - Kougioumtzopoulou, Andromachi S.

AU - Syrigos, Konstantinos N.

AU - Saif, Muhammad Wasif

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Ampullary carcinomas are rare malignancies representing less than 1% of all gastrointestinal cancers. Given the low incidence rate, there is scarcity of data regarding the survival benefit of the treatment options available. In the 2014 ASCO Gastrointestinal Cancers Symposium there were two abstracts that discussed the role of pancreaticoduodenectomy and adjuvant radiation therapy in ampullary carcinoma. The first study (Abstract #366) demonstrated a decline in morbidity and mortality over time for pancreaticoduodenectomy making it a reasonable option for successful treatment of ampullary carcinoma. The second study (Abstract #282) showed that adjuvant radiation therapy in patients with T2 tumors had improved median survival times compared to patients that did not receive radiation therapy.

AB - Ampullary carcinomas are rare malignancies representing less than 1% of all gastrointestinal cancers. Given the low incidence rate, there is scarcity of data regarding the survival benefit of the treatment options available. In the 2014 ASCO Gastrointestinal Cancers Symposium there were two abstracts that discussed the role of pancreaticoduodenectomy and adjuvant radiation therapy in ampullary carcinoma. The first study (Abstract #366) demonstrated a decline in morbidity and mortality over time for pancreaticoduodenectomy making it a reasonable option for successful treatment of ampullary carcinoma. The second study (Abstract #282) showed that adjuvant radiation therapy in patients with T2 tumors had improved median survival times compared to patients that did not receive radiation therapy.

KW - Ampulla of Vater

KW - Neoplasms

KW - Pancreaticoduodenectomy

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84897867793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897867793&partnerID=8YFLogxK

U2 - 10.6092/1590-8577%2F2283

DO - 10.6092/1590-8577%2F2283

M3 - Conference article

C2 - 24618439

AN - SCOPUS:84897867793

SN - 1590-8577

VL - 15

SP - 140

EP - 143

JO - Journal of the Pancreas

JF - Journal of the Pancreas

IS - 2

T2 - 2014 ASCO Gastrointestinal Cancers Symposium

Y2 - 16 January 2014 through 18 January 2014

ER -

Updates in management of ampullary carcinomas

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this